News & Updates

Show Multimedia Only

Real-world use affirms RSVpreF efficacy at preventing LRTD in infants

26 Jul 2025

Maternal immunization with the bivalent respiratory syncytial virus (RSV) prefusion F vaccine (RSVpreF) helps lower the incidence of RSV-related lower respiratory tract disease (LRTD) and severe LRTD leading to hospitalization among infants from birth through age 6 months, according to real-world data from the BERNI study.

Real-world use affirms RSVpreF efficacy at preventing LRTD in infants

26 Jul 2025

$ABI-009 safe in children with refractory epilepsy$

ABI-009 safe in children with refractory epilepsy

25 Jul 2025

In the treatment of paediatric patients with medically and surgically refractory epilepsy, the use of ABI-009 appears safe and tolerable, with early signs of efficacy, according to data from a phase I study.

ABI-009 safe in children with refractory epilepsy

25 Jul 2025

Cardiorespiratory fitness predicts hypertension risk in paediatric population

25 Jul 2025

In children and adolescents, higher cardiorespiratory fitness (CRF) is independently predictive of reduced primary hypertension risk, suggests a study.

Cardiorespiratory fitness predicts hypertension risk in paediatric population

25 Jul 2025

Ivarmacitinib shows favourable risk–benefit profile in AD

24 Jul 2025

The selective oral Janus kinase 1 (JAK1) inhibitor ivarmacitinib helps improve the signs and symptoms of moderate-to-severe atopic dermatitis (AD) in adolescent and adult patients, while having a manageable safety profile, according to a phase III trial.

Ivarmacitinib shows favourable risk–benefit profile in AD

24 Jul 2025

How do parents perceive physical activity in children with cancer?

24 Jul 2025 by

The role of the family is critical to the encouragement of physical activity (PA) among childhood cancer survivors (CCS), according to a Singapore study. Apart from individuals and families, the community and society can also influence participation in PA.

How do parents perceive physical activity in children with cancer?

24 Jul 2025

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-June-2025

23 Jul 2025

New drug applications approved by US FDA as of 1-15 June 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-June-2025

23 Jul 2025

Nirsevimab efficacy against RSV-LRTI hospitalization sustained at 6 months

23 Jul 2025 by

Updated results from the phase IIIB HARMONIE trial demonstrate sustained efficacy of the long-acting monoclonal antibody nirsevimab against respiratory syncytial virus-associated lower respiratory tract infection (RSV-LRTI) hospitalization through day 181 post-dose.

Nirsevimab efficacy against RSV-LRTI hospitalization sustained at 6 months

23 Jul 2025

Early-onset neonatal sepsis ups risk of childhood epilepsy

23 Jul 2025

Infants who contract an invasive bacterial infection during the first week of life have double the risk of epilepsy in childhood, according to a register-based cohort study from Denmark.

Early-onset neonatal sepsis ups risk of childhood epilepsy

23 Jul 2025

Original New Drug Application Approvals by US FDA (16-30 June 2025)

23 Jul 2025

New drug applications approved by US FDA as of 16-30 June 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-30 June 2025)

23 Jul 2025

Inhaled insulin beneficial in youth with diabetes

22 Jul 2025 by

Inhaled insulin appears to be equally efficacious and safe as the injected rapid-acting insulin analogue in children and adolescents with diabetes, according to data from the INHALE-1 study.

Inhaled insulin beneficial in youth with diabetes

22 Jul 2025

News & Updates

Showing Paediatrics articles

Showing

Specialty:

Real-world use affirms RSVpreF efficacy at preventing LRTD in infants

Real-world use affirms RSVpreF efficacy at preventing LRTD in infants

ABI-009 safe in children with refractory epilepsy

ABI-009 safe in children with refractory epilepsy

Cardiorespiratory fitness predicts hypertension risk in paediatric population

Cardiorespiratory fitness predicts hypertension risk in paediatric population

Ivarmacitinib shows favourable risk–benefit profile in AD

Ivarmacitinib shows favourable risk–benefit profile in AD

How do parents perceive physical activity in children with cancer?

How do parents perceive physical activity in children with cancer?

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-June-2025

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-June-2025

Nirsevimab efficacy against RSV-LRTI hospitalization sustained at 6 months

Nirsevimab efficacy against RSV-LRTI hospitalization sustained at 6 months

Early-onset neonatal sepsis ups risk of childhood epilepsy

Early-onset neonatal sepsis ups risk of childhood epilepsy

Original New Drug Application Approvals by US FDA (16-30 June 2025)

Original New Drug Application Approvals by US FDA (16-30 June 2025)

Inhaled insulin beneficial in youth with diabetes

Inhaled insulin beneficial in youth with diabetes